Girolamo Calò Selected Research

Pain (Aches)

1/2021	Novel Mixed NOP/Opioid Receptor Peptide Agonists.
1/2021	Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists.
8/2020	Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
3/2018	Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?
3/2017	Neuropeptide S receptor ligands: a patent review (2005-2016).
1/2013	Hyaluronic acid induces activation of the κ-opioid receptor.
1/2010	Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.
8/2003	Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Girolamo Calò Research Topics

Disease

8	Pain (Aches) 01/2021 - 08/2003
3	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2017
3	Respiratory Hypersensitivity 04/2016 - 02/2010
2	Cough 01/2021 - 03/2005
1	Opioid-Induced Constipation 07/2021
1	Constipation 08/2020
1	Body Weight (Weight, Body) 05/2018
1	Mental Disorders (Mental Disorder) 03/2017
1	Parkinson Disease (Parkinson's Disease) 05/2016
1	Asthma (Bronchial Asthma) 04/2016
1	Neurogenic Inflammation 04/2016
1	Breast Neoplasms (Breast Cancer) 11/2015
1	Hypersensitivity (Allergy) 11/2015
1	Neuralgia (Stump Neuralgia) 11/2015
1	Osteoarthritis 01/2013
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2011
1	Hyperalgesia 01/2010
1	Anxiety Disorders (Anxiety Disorder) 12/2008
1	Gastroesophageal Reflux (GERD) 03/2005
1	Parkinsonian Disorders (Parkinsonism) 12/2004
1	Urinary Incontinence 05/2003

Drug/Important Bio-Agent (IBA)

11	NociceptinIBA 01/2021 - 05/2003
5	Morphine (MS Contin)FDA LinkGeneric 08/2020 - 01/2010
4	Opioid Analgesics (Opioids)IBA 07/2021 - 08/2003
3	Biological ProductsIBA 01/2021 - 03/2017
3	Anti-Anxiety Agents (Anxiolytics)IBA 03/2017 - 12/2008
3	Capsaicin (Zostrix)FDA Link 02/2010 - 03/2005
2	mu Opioid Receptors (mu Opioid Receptor)IBA 07/2021 - 08/2020
2	NeuropeptidesIBA 01/2021 - 05/2016
2	Opioid Receptors (Opioid Receptor)IBA 03/2018 - 11/2015
2	LigandsIBA 03/2017 - 04/2016
2	Analgesics (Analgesic Drugs)IBA 03/2017 - 08/2003
2	Nphe(1)- (pF)Phe(4)- Aib(7)- Arg(14)- Lys(15)- nociceptin-amideIBA 11/2015 - 01/2010
1	naloxegolIBA 07/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Nociceptin ReceptorIBA 01/2021
1	Antitussive Agents (Antitussives)FDA Link 01/2021
1	A-factor (Streptomyces)IBA 05/2018
1	Codeine (Codeine Phosphate)FDA LinkGeneric 05/2018
1	Nootropic Agents (Nootropics)IBA 03/2017
1	Pharmaceutical PreparationsIBA 03/2017
1	Dopamine (Intropin)FDA LinkGeneric 05/2016
1	Immunologic Factors (Immunomodulators)IBA 04/2016
1	Bronchodilator Agents (Bronchodilators)IBA 04/2016
1	Opioid Peptides (Opioid Peptide)IBA 11/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2015
1	AllergensIBA 05/2013
1	Hyaluronic Acid (Hyaluronan)IBA 01/2013
1	TachykininsIBA 03/2005
1	Peptide Receptors (Peptide Receptor)IBA 05/2003

Therapy/Procedure

2	Therapeutics 12/2004 - 08/2003
1	Drug Therapy (Chemotherapy) 11/2015
1	Analgesia 08/2003